Sign in Subscribe

Courses

Access360 courses focus on critical developments reshaping access to innovative medicines in China.
Jun
11
▶️Connecting the Dots for Global Pharma: Critical Factors Driving Success in China

▶️Connecting the Dots for Global Pharma: Critical Factors Driving Success in China

This Q&A explores the growing gap between global pharma strategies and China’s payer priorities—offering a self-assessment tool for internal alignment, and insights into risks and opportunities in the commercial catalog pathway.
3 min read
May
08
Positioning for Success: Navigating China’s C-List and Commercial Catalog for Innovative Medicines

Positioning for Success: Navigating China’s C-List and Commercial Catalog for Innovative Medicines

Gain practical tools and insight to navigate China’s C-List and Commercial Catalog—and make informed decisions on product positioning across emerging access pathways.
2 min read
Oct
15
▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
1 min read